The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Fortis Healthcare Ltd

Fortis Healthcare Ltd

BSE 532843 · NSE FORTIS · ISIN INE061F01013 · Group A · Active

Healthcare › Healthcare › Healthcare Services › Hospital

₹916.20

-0.20%

BSE close, 28 August 2026

Market cap

₹69,169.27 cr

75.5 cr shares · Mid cap

Free float

₹47,606.85 cr

as published

P/E · P/B

305.4× · 7.62×

EPS ₹3.00 · BV ₹120.24

FY25-26 rev / PAT

1,792.50 / 230.34

₹ cr, as filed

Filings, window

35

9 selected · 26%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹767.30 52-WK HIGH ₹1,105.00 ₹916.20 44% of range
Against 52-week high-17.1%
Against 52-week low+19.4%
Day change-0.20%
Size bandMid cap
Index membershipNIFTY 500, NIFTY INFRASTRUCTURE

Valuation as published by BSE

Earnings per share₹3.00
Price / earnings305.40×
Price / book7.62×
Book value — derived, price ÷ P/B₹120.24
Return on equity2.49%
Operating margin27.82%
Net margin9.76%

Consistency check

P/B ÷ P/E, which must equal ROE
2.50%
ROE as published
2.49%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 489.45 47.78 0.63 27.82% 9.76%
Mar-26 · Q 460.73 24.98 0.33 24.91% 5.42%
FY25-26 1,792.50 230.34 3.05 33.10% 12.85%

Quarter on quarter

Revenue, quarter on quarter
+6.2%
Net profit, quarter on quarter
+91.3%
Operating margin, quarter on quarter
+291 bps

Disclosure profile 35 filings in the window

0 median 17.0 p75 · 25 sector max 52 35 94th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

35 filings · 9 selected · busiest 2026-08-06

Filing rhythm · the twelve most recent

2026-09-092026-09-29

SelectedProcedural

Filings

35 in the window · 16 earlier on record

  1. 29 September 2026 ·

    General

    Announcement / Press Release Filed By IHH Healthcare Berhad ('IHH')

    The relevant disclosure is attached.

    Company Update / General View filing →

  2. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    The relevant disclosureis attached.

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 25 September 2026 ·

    General

    Update On Material Litigation Filed By Northern TK Venture Pte Ltd. ('NTK'), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company, Limited Before The Tokyo District Court In Japan

    The relevant disclosure is attached

    Company Update / General View filing →

  4. 16 September 2026 ·

    Press Release

    Press Release / Media Release

    The relevant disclosure is attached.

    Company Update / Press Release / Media Release View filing →

  5. 16 September 2026 ·

    General

    Intimation For Signing The Definitive Agreements By Fortis Hospotel Limited (Wholly Owned Subsidiary Of The Company) To Provide Healthcare Services To A 400+ Bedded Super Specialty Hospital In Ashok Vihar, New Delhi

    The relevant disclosure is attached.

    Company Update / General View filing →

  6. 16 September 2026 ·

    General

    Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 About Filing Of Special Leave Petition ('SLP') Before The Hon'Ble Supreme Court Of India

    The relevant disclosure is attached.

    Company Update / General View filing →

  7. 15 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    The Relevant Disclosure is Attached.

    Company Update / Analyst / Investor Meet View filing →

  8. 15 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    The Relevant Disclosure is Attached.

    Company Update / Analyst / Investor Meet View filing →

  9. 11 September 2026 ·

    General

    Update On Material Litigation Filed By Northern TK Venture Pte Ltd. ('NTK'), The Promoter Shareholder Of The Company, Against Daiichi Sankyo Company, Limited Before The Tokyo District Court In Japan.

    The relevant disclosure is attached.

    Company Update / General View filing →

  10. 10 September 2026 ·

    Concall Transcript

    Earnings Call Transcript

    The relevant disclosure is attached.

    Company Update / Earnings Call Transcript View filing →

  11. 9 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    The revised Intimation is attached.

    Company Update / Analyst / Investor Meet View filing →

  12. 9 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    The revised Intimation is attached.

    Company Update / Analyst / Investor Meet View filing →

  13. 9 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    The relevant disclosure is attached

    Company Update / Analyst / Investor Meet View filing →

  14. 9 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    The relevant disclosre is attached.

    Company Update / Analyst / Investor Meet View filing →

  15. 4 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    The Relevant disclosure is attached.

    Company Update / Analyst / Investor Meet View filing →

  16. 1 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    The Relevant Disclosure is Attached.

    Company Update / Analyst / Investor Meet View filing →

  17. 1 September 2026 ·

    General

    Regarding Order Passed By The Hon'Ble Delhi High Court In Relation To Certain Applications Filed By Daiichi Sankyo Company, Limited Inter Alia The Company. Detailed Disclosure Is Attached.

    Relevant disclosure is attached.

    Company Update / General View filing →

  18. 24 August 2026 ·

    General

    ESG Rating

    The relevant disclosure is attached.

    Company Update / General View filing →

  19. 11 August 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Relevant disclosure attached

    Company Update / Earnings Call Transcript View filing →

  20. 11 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Relevant disclosure attached

    AGM/EGM / AGM View filing →

  21. 11 August 2026 ·

    AGM / EGM

    Summary Of The Proceedings Of The 30Th Annual General Meeting.

    The relevant disclosure is attached.

    AGM/EGM / AGM View filing →

  22. 11 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceeding of 30th Annual General Meeting

    AGM/EGM / AGM View filing →

  23. 7 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Relevant disclosure is attached

    Company Update / Newspaper Publication View filing →

  24. 7 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Relevant disclosure is attached

    Company Update / Analyst / Investor Meet View filing →

  25. 6 August 2026 ·

    Investor Presentation

    Investor Presentation

    The relevant disclosure is attached.

    Company Update / Investor Presentation View filing →

  26. 6 August 2026 ·

    Press Release

    Press Release / Media Release

    The relevant disclosure is attached.

    Company Update / Press Release / Media Release View filing →

  27. 6 August 2026 ·

    Change in Management

    Change in Management

    Appointment of Tax Auditor

    Company Update / Change in Management View filing →

  28. 6 August 2026 ·

    Results

    Financial Results Quarter Ended June 30, 2026

    The Relevant disclosure is attached

    Result / Financial Results View filing →

  29. 6 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    The relevant disclosure is attached

    Board Meeting / Outcome of Board Meeting View filing →

  30. 5 August 2026 ·

    General

    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    The relevant disclosure is attached.

    Company Update / General View filing →

  31. 31 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Relevant disclosure is attached

    Company Update / Analyst / Investor Meet View filing →

  32. 30 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Relevant Disclosure is attached

    Company Update / Analyst / Investor Meet View filing →

  33. 30 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026.

    Fortis Healthcare Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve the Un-audited financial ....

    Board Meeting / Board Meeting View filing →

  34. 21 July 2026 ·

    General

    Intimation On Tax Deduction At Source (TDS) / Withholding Tax On Dividend

    Relevant disclosure is attached.

    Company Update / General View filing →

  35. 20 July 2026 ·

    Press Release

    Press Release / Media Release

    Agilus Diagnostics Limited(Subsidiary of the Company) appoints Vijender Singh as Managing Director and Chief Executive Officer

    Company Update / Press Release / Media Release View filing →

RSS feed for Fortis Healthcare Ltd · the 50 most recent filings